Randomized clinical trial comparing efficacy and safety of brand versus generic alendronate (Bonmax®) for osteoporosis treatment.
Although the same efficacy and tolerability are anticipated due to both drugs containing the same active ingredients, comparative studies between brand and generic alendronate are limited. Accordingly, the objective of this study was to compare efficacy and safety between brand alendronate and a rec...
Main Authors: | Aasis Unnanuntana, Atthakorn Jarusriwanna, Panupan Songcharoen |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2017-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC5498028?pdf=render |
Similar Items
-
High-dose versus low-dose ergocalciferol for correcting hypovitaminosis D after fragility hip fracture: a randomized controlled trial
by: Atthakorn Jarusriwanna, et al.
Published: (2021-01-01) -
Efficacy of generic alendronate and ibandronate in post menopausal osteoporosis
by: NP Somasundaram, et al.
Published: (2012-03-01) -
Efficacy and safety of alendronic acid in the treatment of osteoporosis in children
by: Alberto Martín Siguero, et al.
Published: (2015-11-01) -
Comparative safety and effectiveness of alendronate versus raloxifene in women with osteoporosis
by: Yeesuk Kim, et al.
Published: (2020-07-01) -
Comparing tolerability and efficacy of generic versus brand alendronate: a randomized clinical study in postmenopausal women with a recent fracture.
by: Joop P W van den Bergh, et al.
Published: (2013-01-01)